— Know what they know.
Not Investment Advice
Also trades as: MVP.AX (ASX) · $vol 0M

MDDVF OTC

Medical Developments International Limited
1W: +0.0% 1M: -5.1% 3M: -14.2% YTD: +4.5% 1Y: -1.0% 3Y: -39.9% 5Y: -93.7%
$0.32
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 41 · $35.8M mcap · 98M float · 0.0003% daily turnover · Short 78% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$35.8M
52W Range0.3038-0.37065
Volume2,500
Avg Volume327
Beta1.41
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBrent MacGregor
Employees68
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-01-21
4 Caribbean Drive
Scoresby, VIC 3179
AU
61 3 9547 1888
About Medical Developments International Limited

Medical Developments International Limited is a global provider of essential medical solutions, engaged in both their manufacturing and distribution. The company's reach extends throughout Australia, Europe, the United States, and other international markets, with its operations divided into two primary segments: Pain Management and Respiratory. Within its respiratory division, it develops devices to assist individuals afflicted with conditions such as asthma and chronic obstructive pulmonary disease. For pain relief, a cornerstone product is Penthrox, utilized in trauma and emergency scenarios. Furthermore, Medical Developments International offers a diverse selection of medical instruments, including CPR equipment like face shield keyrings and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, and various oxygen therapy and resuscitation kits and masks. Founded in 2003, the company's main office is located in Scoresby, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms